Astragaloside IV represses high glucose-induced mesangial cells activation by enhancing autophagy via SIRT1 deacetylation of NF-κB P65 subunit
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
AIM: Mesangial cell (MC) activation plays an important role in many glomerular diseases associated with renal fibrosis, including diabetic kidney disease (DKD). The aim of this study was to determine whether Astragaloside IV (AS-IV) modulated MC activation in DKD via autophagy by specifically regulating the autophagy inducer sirtuin 1 (SIRT1). METHODS: Cultured MCs and diabetic KK-Ay mice were treated with AS-IV, and the markers and regulatory mediators of autophagy were analyzed using Western blotting, real-time PCR, ELISA and IF. RESULTS: AS-IV inhibited MC activation and enhanced autophagy in hyperglycemic conditions by increasing SIRT1 expression and decreasing NF-κB p65 acetylation. In addition, the SIRT1 activator SRT1720 enhanced autophagy and decreased p65 acetylation during hyperglycemia-induced MC activation. Opposite effects were seen with the SIRT1 inhibitor EX527. Furthermore, the ameliorative effect of AS-IV on MCs was abolished by the autophagy inhibitor 3-MA, while the autophagy activator rapamycin restored hyperglycemia-induced MC activation. Finally, AS-IV improved renal function and fibrosis in the diabetic KK-Ay mice. CONCLUSION: AS-IV ameliorated renal function and morphology by inducing autophagy and inhibiting MC activation through the SIRT1-NF-κB pathway, indicating a potential therapeutic role of AS-IV in glomerular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, Astragaloside IV, a saponin purified from the Astragalus root, prevented DKD progression by stimulating autophagy in diabetic mice189-191”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
Lee, I. H., Cao, L., Mostoslavsky, R., Lombard, D. B., Liu, J., Bruns, N. E., Tsokos, M., Alt, F. W., & Finkel, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712145105 · Cited by 1,476 · cited 2×
“26 Chuang et al 28 showed that podocyte autophagy was suppressed in SIRT1 knockout mice.”
Hariharan, N., Maejima, Y., Nakae, J., Paik, J., DePinho, R. A., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.110.227371 · Cited by 692 · cited 1×
“8 Studies have showed that SIRT1 plays a protective role in the onset and progression of DKD. 7 A previous study showed that SIRT1 de-acetylated and inactivated NF-κ B in MCs, thereby inhibiting their expansion and alleviating renal damage in a streptozotocin (STZ)-induced diabetic rat model.”
Deacetylation of Nuclear LC3 Drives Autophagy Initiation under Starvation
Huang, R., Xu, Y., Wan, W., Shou, X., Qian, J., You, Z., Liu, B., Chang, C., Zhou, T., Lippincott-Schwartz, J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.013 · Cited by 662
The pathogenesis of diabetic nephropathy
Dronavalli, S., Duka, I., & Bakris, G. L. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0894 · Cited by 625
Real-time PCR quantification of precursor and mature microRNA
Schmittgen, T. D., Lee, E. J., Jiang, J., Sarkar, A., Yang, L., Elton, T. S., & Chen, C. (2008) · Methods · doi:10.1016/j.ymeth.2007.09.006 · Cited by 616 · cited 1×
“Real-time PCR primers were designed as described previously.(19) Relative expression was calculated using the comparative cycle threshold (Ct) method (2-ΔΔCT).”
SIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging
Chang, H.-C., & Guarente, L. (2013) · Cell · doi:10.1016/j.cell.2013.05.027 · Cited by 615 · cited 1×
“Sirtuin 1 (SIRT1), a deacetylase regulating several enzymes, proteins, and transcription factors, 4,5 is involved in many physiological processes such as cellular senescence, 6 metabolism, 7 and stress responses.”
Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases
Cybulsky, A. V. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.129 · Cited by 526
Kume, S., Haneda, M., Kanasaki, K., Sugimoto, T., Araki, S.-I., Isshiki, K., Isono, M., Uzu, T., Guarente, L., Kashiwagi, A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605904200 · Cited by 233 · cited 1×
“9,10,25 For instance, activation of SIRT1 retarded the ECM accumulation in MCs exposed to TGF-β 1.”
Abboud, H. E. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.025 · Cited by 215 · cited 1×
“3 Therefore, it is necessary to explore the underlying mechanisms of MC activation in order to block the progression of diabetic glomerulosclerosis.”
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Pharmacological Effects of Astragaloside IV: A Review
Liang, Y., Chen, B., Liang, D., Quan, X., Gu, R., Meng, Z., Gan, H., Wu, Z., Sun, Y., Liu, S., et al. (2023) · Molecules · doi:10.3390/molecules28166118 · Cited by 200
“diabetic KK-Ay mice Feeding KK-Ay mice a high-fat diet Inducing autophagy and inhibiting MC activation through the SIRT1-NF-κB pathway [49]”
MethodLi, X., Jamal, M., Guo, P., Jin, Z., Zheng, F., Song, X., Zhan, J., & Wu, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109363 · Cited by 196
Ma, X., Ma, J., Leng, T., Yuan, Z., Hu, T., Liu, Q., & Shen, T. (2023) · Renal Failure · doi:10.1080/0886022x.2022.2146512 · Cited by 176
Zhang, Y., Zhang, Y. W., Jin, X., Zhou, X.-H., Dong, X.-H., Yu, W., & Gao, W. (2019) · Molecules · doi:10.3390/molecules24091838 · Cited by 156
Tang, X., Li, X., Zhang, D., & Han, W. (2022) · Bioengineered · doi:10.1080/21655979.2022.2049471 · Cited by 140
Accelerated Kidney Aging in Diabetes Mellitus
Guo, J., Zheng, H. J., Zhang, W., Lou, W., Xia, C., Han, X. T., Huang, W. J., Zhang, F., Wang, Y., & Liu, W. J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1234059 · Cited by 93
GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy
Zuo, Y., Chen, L., Gu, H., He, X., Ye, Z., Wang, Z., Shao, Q., & Xue, C. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.27 · Cited by 106
Gong, P., Xiao, X., Wang, S., Shi, F., Liu, N., Chen, X., Yang, W., Wang, L., & Chen, F. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114558 · Cited by 97
RetractedQuercetin-mediated SIRT1 activation attenuates collagen-induced mice arthritis
Shen, P., Lin, W., Ba, X., Huang, Y., Chen, Z., Han, L., Qin, K., Huang, Y., & Tu, S. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114213 · Cited by 86
Meng, X., Liu, X., Tan, J., Qi, S., Zhang, D., Li, B., Zhang, J., Zhang, F., Chen, H., Cui, T., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00783-z · Cited by 77
Autophagy and its therapeutic potential in diabetic nephropathy
Han, Y.-P., Liu, L., Yan, J.-L., Chen, M., Meng, X., Zhou, X., & Qian, L.-B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1139444 · Cited by 74
Jaikumkao, K., Promsan, S., Thongnak, L., Swe, M. T., Tapanya, M., Htun, K. T., Kothan, S., Intachai, N., & Lungkaphin, A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30316 · Cited by 58
Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
Tovar‐Palacio, C., Noriega, L. G., & Mercado, A. (2022) · Nutrients · doi:10.3390/nu14030653 · Cited by 55
Astragalus Mongholicus: A review of its anti-fibrosis properties
Gong, F., Qu, R., Li, Y., Lv, Y., & Dai, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.976561 · Cited by 55
The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
Gao, Y., Su, X., Xue, T., & Zhang, N. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114598 · Cited by 56
Self-citationZhang, Y., Tao, C.-H., Xuan, C., Jiang, J., & Cao, W. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9542165 · Cited by 51
Targeting the AMPK/Nrf2 Pathway: A Novel Therapeutic Approach for Acute Lung Injury
Huang, Q., Ren, Y., Yuan, P., Huang, M., Liu, G., Shi, Y., Jia, G., & Chen, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s467882 · Cited by 46
Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus
Wang, J., Wang, S., Wang, J., Xiao, M., Guo, Y., Tang, Y., Zhang, J., & Gu, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.598012 · Cited by 44
SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms
Qi, W., Hu, C., Zhao, D., & Li, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.801303 · Cited by 43
Wang, T., Gao, Y., Yue, R., Wang, X., Shi, Y., Xu, J., Wu, B., & Li, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/2735714 · Cited by 42
Self-citationYang, Y., Hong, M., Lian, W., & Chen, Z. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i28.10004 · Cited by 42
The role of autophagy in the treatment of type II diabetes and its complications: a review
Zhao, X., Bie, L., Pang, D.-R., Li, X., Yang, L., Chen, D., Wang, Y.-R., & Gao, Y. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1228045 · Cited by 41
Self-citationSu, X., Guo, H., Zhou, Y., Cao, A., Shen, Q., Zhu, B., Yao, X., Wang, Y., Wang, H., & Wang, L. (2023) · Phytotherapy Research · doi:10.1002/ptr.7875 · Cited by 38
Mechanisms of Herbal Nephroprotection in diabetes mellitus
Dragoș, D., Manea, M. M., Timofte, D., & Ionescu, D. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5710513 · Cited by 36
Zhou, X., Zou, J., Ao, C., Gong, D., Chen, X., & Ma, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105192 · Cited by 37
Autophagy, Pyroptosis and Ferroptosis are Rising Stars in the Pathogenesis of Diabetic Nephropathy
Li, X., Gao, L., Li, X., Xia, J., Pan, Y., & Bai, C. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s450695 · Cited by 35
Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy
Wang, Y., Zhao, H., Wang, Q., Zhou, X., Lu, X., Liu, T., Zhan, Y., & Li, P. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9030893 · Cited by 33
Qu, C., Tan, X., Hu, Q., Tang, J., Wang, Y., He, C., He, Z., Li, B., Fu, X., & Du, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26863 · Cited by 32
Roles of Sirt1 and its modulators in diabetic microangiopathy: A review
Jin, Q., Liu, T., Ma, F., Fu, T., Yang, L., Mao, H., Wang, Y., Peng, L., Li, P., & Zhan, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130761 · Cited by 31
mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets
Shi, J., Liu, X., Jiao, Y., Tian, J., An, J., Zou, G., & Zhuo, L. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101260 · Cited by 30
PARP-1 and SIRT-1 are Interacted in Diabetic Nephropathy by Activating AMPK/PGC-1α Signaling Pathway
Zhu, H., Fang, Z., Chen, J., Yang, Y., Gan, J., Luo, L., & Zhan, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291314 · Cited by 30
Li, R., Tao, H., Pan, K., Li, R., Guo, Z., Chen, X., & Li, Z. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04265-x · Cited by 29
Xue, H.-Z., Chen, Y., Wang, S.-D., Yang, Y.-M., Cai, L.-Q., Zhao, J., Huang, W., & Xiao, Y. (2024) · Journal of Diabetes Research · doi:10.1155/2024/5216113 · Cited by 28
Zhang, W., Liu, M., Liu, Y., Huang, F., Lan, Y., Li, H., Wu, H., Zhang, B., Shi, H., & Wu, X. (2019) · Molecules · doi:10.3390/molecules24030561 · Cited by 26
Ge, C., & He, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.556984 · Cited by 24
Astragaloside IV attenuates IL-1β secretion by enhancing autophagy in H1N1 infection
Zhang, J., Zhang, W., Ren, L., He, Y., Mei, Z., Feng, J., Shi, T., Zhang, H., Song, Z., & Jie, Z. (2020) · FEMS Microbiology Letters · doi:10.1093/femsle/fnaa007 · Cited by 22
Li, T., Gao, X., Jia, R., Sun, Y., Ding, Y., Wang, F., & Wang, Y. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.2.18 · Cited by 20
Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy
Li, Q., Xu, H., Ma, R.-T., Ma, Y.-Y., & Chen, M. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01641-3 · Cited by 18
Natural products in traditional Chinese medicine for renal fibrosis: a comprehensive review
Zhao, Q., Jin, M., Zhao, Q., Wang, Z., Zhao, C., Xue, X., Qiao, X., Qu, P., Han, D., & Tao, R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1560567 · Cited by 18
Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy
Li, Y., Tian, Z., Pan, G., Zhao, P., Pan, D.-J., Zhang, J., Ye, L.-Y., Zhang, F., & Xu, X.-D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.977284 · Cited by 18
Tran, Q., Tran, G. V., Velic, S., Xiong, H.-M., Kaur, J., Moosavi, Z., Nguyen, P., Duong, N., Luu, V. T., Singh, G., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020774 · Cited by 17
Shi, X., Chang, M., Zhao, M., Shi, Y., & Zhang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113916 · Cited by 17
Xu, J., Chen, Y., Xing, Y., & Ye, S. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13120 · Cited by 17
Self-citationJin, Q., Liu, T., Ma, F., Yang, L., Mao, H., Wang, Y., Li, P., Peng, L., & Zhan, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115499 · Cited by 16
Therapeutic effect and mechanism of combined use of FGF21 and insulin on diabetic nephropathy
Meng, F., Cao, Y., Khoso, M. H., Kang, K., Ren, G., Xiao, W. L., & Li, D. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109063 · Cited by 15
Promsan, S., Thongnak, L., Pengrattanachot, N., Phengpol, N., Sutthasupha, P., & Lungkaphin, A. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113190 · Cited by 15
The critical role of dysregulated autophagy in the progression of diabetic kidney disease
Zhang, Z., Sun, Y., Xue, J., Jin, D., Li, X., Zhao, D., Lian, F., Qi, W., & Tong, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.977410 · Cited by 15
Zhou, X., Wang, X., Lu, L., Deng, M., & Shi, X. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0454 · Cited by 13
Self-citationPark, J. Y., Han, S., Ka, H. I., Joo, H. J., Soh, S., Yoo, K. H., & Yang, Y. (2019) · Cancer Science · doi:10.1111/cas.14147 · Cited by 13
Guo, Y., Xue, T., Meng, X.-F., Yan, P., Zhang, M., Zhang, Q., Li, T., Shi, K., & Zhang, N. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157399 · Cited by 12
Self-citationAstragaloside IV: A multipotent phytochemical for treating fibrotic diseases (Review)
Wu, M., Li, K., Wu, J., Zhang, Q., Ma, X., Dai, W., Gao, H., Ding, X., Wang, W., & Xiao, W. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5721 · Cited by 10
Li, Y., Song, L., Du, Y., & Jiang, X. (2024) · Current Molecular Medicine · doi:10.2174/0115665240310818240531080353 · Cited by 8
Yang, Q., Li, T., Lu, Y., Wang, T., Chen, Z., Xing, G., Wei, Q., Cao, X., & Yao, J. (2025) · Hearing Research · doi:10.1016/j.heares.2025.109432 · Cited by 4
Self-citationLu, K., Wu, S.-C., Lu, T.-C., Tzeng, I.-S., Kuo, C. A., Hung, Y., Wu, S.-Y., Chen, T., Tsai, M.-K., Chuang, C., et al. (2024) · Aging · doi:10.18632/aging.206170 · Cited by 3
Deng, Q., Li, C., Luo, J., Yin, M., Qian, S., & Li, L. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2667561 · Cited by 3
“…astragaloside iv targets Sirt1 as its core, exerting dual protective effects. first, it inhibits the transcriptional activity of Nf-κB p65 via Sirt1-mediated deacetylation, attenuating inflammation and enhancing autophagy, thereby suppressing mesangial cell activation and glomerulosclerosis [133].”
CHEN, C. X. R., He, P., Liu, Y., Ma, J., Zhai, H., & Yu, R. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s600460 · Cited by 3
Could Cyclosiversioside F Serve as a Dietary Supplement to Prevent Obesity and Relevant Disorders?
Qin, S., Chen, J., Zhong, K., Li, D., & Peng, C. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813762 · Cited by 3
“In addition, CSF intervention promoted the activation of MCs through restraining p65 acetylation, decreasing of mAlb, and increasing Beclin 1 and LC3 II via enhancing SIRT1 levels [75].”
BackgroundZhang, X., & Liu, H. (2026) · Xenobiotica · doi:10.1080/00498254.2025.2612600 · Cited by 2
Zhong, C., Sun, Z., Li, D., Yang, L., Lu, Y., Li, C., Cui, L., Liu, J., & Zhuo, Y. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106950 · Cited by 1
[3-Methyladenine alleviates early renal injury in diabetic mice by inhibiting AKT signaling].
Liu, B., Wang, Y., Ren, H., Ou, L., Deng, X., Huang, M., Wu, X., & Gong, Q. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.07.03 · Cited by 1
Astragaloside IV prophylactic administration relieves recurrent allergic atopic dermatitisPreprint
Zheng, J., Yu, X., Wei, X., Fan, H., & Hong, M. (2020) · doi:10.21203/rs.3.rs-23795/v1
Potential of Small-Molecule Natural Products Against Autophagy Dysfunction in Kidney Diseases
Shoyshob, T. Z., Afrin, N., Islam, M. M., Farjana, M., Roni, M. T. A., Sen, M., Azam, M. S., Hridoy, A. I., Moni, A., & Uddin, M. J. (2026) · Immuno · doi:10.3390/immuno6020022
Jiang, Y., xing, H., Li, L., Jin, W., Tang, H., Hu, S., Wang, Z. P., Luo, Y., Zhu, Y., & Xing, Q. (2026) · Open Life Sciences · doi:10.1515/biol-2025-1330
Shi, J., Zhou, X., Wu, J., Zeng, L., Wang, X., Li, W., Huang, X.-S., Deng, X., & Wang, W. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5920 · Cited by 1
Self-citationThe Therapeutic Application of Epigenetic Regulation by Natural Herbal Compounds in Kidney Diseases
Bai, Q., Luo, K.-M., Jia, L., Jia, J., Kantawong, F., Tan, R., & Wang, L. (2026) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2026.151711
Li, S., Zhang, S., Cui, L., Li, Y., Wang, Y., & Wang, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1867891
Zhao, X., Bie, L.-Y., Pang, D.-R., Li, X., Yang, L.-F., Chen, D.-D., Wang, Y.-R., & Gao, Y. (2023) · doi:10.3389/fendo.2023.1228045.s001
Self-citation
Metadata
- Authors
- Wang, X., Gao, Y., Tian, N., Zhu, Z., Wang, T., Xu, J., Wu, B., & Zhang, N.
- Affiliations
- Capital Medical University (CN)
- Corresponding author
- Gao, Yanbin
- Venue
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Published
- 2018-09
- Volume
- Volume 12
- Pages
- 2971-2980
- ISSN
- 1177-8881 (ISSN-L)
- PMC
- PMC6140761
- OpenAlex
- W2890948470
- Cited by
- 63
- References
- 35
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 11 · 2021: 7 · 2020: 8 · 2019: 6
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Drug Design Development and Therapy (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Key Research and Development Program of China (2012CB518602)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- astragaloside IV, mesangial cell activation, autophagy, SIRT1, NF-κB p65 acetylation, diabetic nephropathy, hyperglycemia, renal fibrosis, glomerular disease, SRT1720, EX527, rapamycin, 3-methyladenine
- MeSH terms
- Acetylation, Animals, Autophagy, Cells, Cultured, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Disease Models, Animal, Dose-Response Relationship, Drug, Glucose, Male, Mice, Inbred C57BL, Saponins, Structure-Activity Relationship, Triterpenes, Cell Proliferation, Mesangial Cells, Mice, Transcription Factor RelA, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.